beta
TCRT
Alaunos Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
ziopharm oncology, inc., is a biopharmaceutical company focused on the discovery and development of new cancer therapies. we are applying the latest technologies in cancer research to develop safer, more precise therapeutics to improve care and quality of life for patients.
Market Cap: 452 Million
Primary Exchange: NASDAQ
Website: ziopharm.com
Shares Outstanding: 241 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.083065622103808
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 182 trading days
From: 2023-05-15 To: 2024-01-31
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|